Log In
Print this Print this

RDD 1219 Capository, intra-anal nifedipine (RDD-1219)

Also known as: RDD 1219

  Manage Alerts
Collapse Summary General Information
Company RDD Pharma Ltd.
DescriptionCalcium channel blocker delivered via a sustained-release, coated suppository device
Molecular Target Calcium channel
Mechanism of ActionCalcium channel blocker
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentPhase III
Standard Indication Gastrointestinal (unspecified)
Indication DetailsTreat chronic anal fissures
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today